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Abstract
Objective—This study examined the phenotypic effects of adipocyte-specific oncostatin M
receptor (OSMR) loss in chow-fed mice.
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Methods—Chow-fed adipocyte-specific OSMR knockout (FKO) mice and littermate OSMRfl/fl
controls were studied. Tissue weights, insulin sensitivity, adipokine production, and stromal cell
immunophenotypes were assessed in epididymal fat (eWAT); serum adipokine production was
also assessed. In vitro, adipocytes were treated with oncostatin M (OSM) and adipokine gene
expression assessed.
Results—Body weights, fasting blood glucose levels, and eWAT weights did not differ between
genotypes. However, the eWAT of OSMRFKO mice was modestly less responsive to insulin
stimulation than that of OSMRfl/fl mice. Notably, significant increases in adipokines including Creactive protein, lipocalin 2, intercellular adhesion molecule-1 (ICAM-1), and insulin-like growth
factor binding protein 6, were observed in the eWAT of OSMRFKO mice. In addition, significant
increases in fetuin A and ICAM-1 were detected in OSMRFKO serum. Flow cytometry revealed a
significant increase in leukocyte number and modest, but not statistically significant, increases in
B and T cells in the eWAT of OSMRFKO mice.
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Conclusions—The chow-fed OSMRFKO mouse exhibits adipose tissue dysfunction and
increased pro-inflammatory adipokine production. These results suggest that intact adipocyte
OSM-OSMR signaling is necessary for adipose tissue immune cell homeostasis.
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INTRODUCTION
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A coordination among healthy adipocytes and stromal vascular cells (SVCs, including
immune cells, preadipocytes, and endothelial cells) in the local adipose tissue environment is
critical to maintain homeostasis of both adipose tissue and systemic metabolism. Obesity is
intimately coupled to a chronic, low-grade inflammatory state characterized by leukocyte
infiltration of adipose tissue and subsequent modulation of the tissue adipokine profile.
Activation of infiltrating leukocytes and promotion of pro-inflammatory adipokine
production can enable adipose tissue dysfunction and lead to temporal effects on metabolic
homeostasis (1, 2, 3, 4).
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Oncostatin M (OSM), an adipokine belonging to the interleukin-6/gp130 family of
cytokines, regulates a variety of physiological and pathological processes (5, 6). First
recognized in 1986 for its anti-tumorigenic effects (7), it is now evident that OSM can
regulate many other biological processes in a cell-type dependent manner (8). OSM is a
unique gp130 cytokine in that it has its own specific receptor subunit (OSM receptor β or
OSMR) that heterodimerizes with gp130 to create a functional OSM receptor complex,
which produces the majority of OSM effects (9). Adipocytes in particular exhibit extensive
responses to OSM (10, 11), and OSMR is highly expressed in adipose tissue (12).
Importantly, though adipocytes express OSMR, they do not produce OSM itself. Rather,
OSM is produced in various adipose tissue SVCs including macrophages, T cells, and B
cells (10, 12). Increased adipose tissue expression of OSM and OSMR are correlates of
obesity in both mouse and man (12). We have previously shown that adipocyte-specific
deletion of OSMR in mice (referred to here as OSMRFKO mice) is associated with
augmented adipose tissue inflammation and systemic insulin resistance and obesity (10).
Notably, adipose tissue OSM expression itself is elevated in obese OSMRFKO mice (10).
While we have demonstrated its role in perpetuating inflammation and systemic insulin
resistance in the obese condition (10), it remains unclear what potential effects disrupted
adipose tissue OSM signaling has in the absence of obesity.
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With the present study, we examined the function of adipose tissue OSM signaling in the
absence of an obesogenic stimulus such as a high-fat diet. Our novel observations
demonstrate that, in the absence of obesity, OSMRFKO mice exhibit leukocyte accumulation,
increased pro-inflammatory adipokine production, and a modest reduction of adipose tissue
insulin responsiveness. These effects occur in the absence of differences in body weight or
adiposity. These results corroborate our previous observations that intact adipocyte OSM
signaling is necessary for maintenance of adipose tissue homeostasis, and demonstrate that
adipose tissue dysfunction precedes systemic metabolic dysfunction in this model.
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METHODS
Animals and Husbandry
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Mixed background OSMRFKO mice and homozygous floxed littermates (OSMRfl/fl) were
obtained from our in-house colony, which was generated using adiponectin–Cre and OSMR
floxed mice as previously described (10). All mice used in these studies were male, were 6–
9 months of age, and were maintained on LabDiet #5015 (LabDiet, St. Louis, MO) from
weaning (3 weeks of age) until study termination. Mice were housed in a temperature (22°
± 2° Celsius) - and humidity-controlled (45–55%) room under a 12-hour light/dark cycle,
and allowed ad libitum access to food and water. Tissue OSMR and gp130 gene and protein
expression, 4-hour blood glucose measurement, and eWAT insulin sensitivity studies (acute
intraperitoneal insulin injections) were performed on one cohort of mice. Acute OSM
injection studies were conducted in a second cohort of mice, tissue adipokine studies were
conducted in mice from the protein expression cohort and in a third cohort. Serum adipokine
studies were also conducted in third cohort. Flow cytometry studies were performed in an
additional cohort of 6-month old mice. The Pennington Biomedical Research Center
Institutional Animal Care and Use Committee approved all studies (protocol #961P).
Acute OSM injection experiments
Fed mice (n=4 OSMRfl/fl and n=4 OSMRFKO) were given acute injections of 200 ng
recombinant murine OSM (mOSM; R&D Systems; Minneapolis, MN; catalog #495MO-025) or vehicle (sterile 0.1% BSA in PBS) and sacrificed 15 minutes later. Epididymal
fat pads were excised, snap frozen, and stored at −80°C for immunoblotting analyses as
described below.
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Cell culture and treatments
Murine 3T3-L1 preadipocytes were grown to 2 days post-confluence in DMEM with 10%
fetal bovine serum (FBS) and differentiated as described previously (10). One day prior to
beginning OSM treatment of adipocytes, medium was replaced with DMEM containing 5%
FBS. Cells were pretreated with 50 μM of the ERK inhibitor U0126 for 1 hour, and then
1nM recombinant mOSM or vehicle (0.1% BSA in PBS) was added as indicated. Six hours
later, medium was removed, and cells were washed with PBS and then harvested for RNA
extraction. Experiments were performed in duplicate.
Gene expression analyses
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Total RNA was isolated from indicated mouse tissues or 3T3-L1 adipocytes using an
RNeasy Mini Kit (Qiagen; Germantown, MD) and yield determined by spectrophotometry
(NanoDrop Technologies; Wilmington, DE) as previously described (10). cDNA was
synthesized using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems;
Foster City, CA) with the SYBR Green system (Clontech; Mountain View, CA). Relative
quantification of mRNA expression was analyzed using an ABI Prism 7900 Sequence
Detection System (Applied Biosystems; Foster City, CA). Sequences for mouse primers
(Integrated DNA Technologies; San Diego, CA) appear in Table 1.
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Proteins were separated on 7.5% (OSMR, gp130) or 10% (Akt, ERK, phosphoSTAT3/5)
polyacrylamide gels containing sodium dodecyl sulfate and transferred to nitrocellulose
membranes as previously described (10). After transfer, membranes were blocked and
incubated with goat anti-OSMR (R&D Systems; Minneapolis, MN; catalog #AF662), rabbit
anti-STAT5A (Santa Cruz Biotechnology; Dallas, TX; catalog #sc-1081), or mouse antiphosphoSTAT5 (Millipore Sigma; Burlington MA; catalog #05-495) primary antibodies
(1:1000 dilution) overnight at 4°C. Results were visualized with appropriate horseradish
peroxidase-conjugated secondary antibodies (1:15,000 dilution) (Jackson ImmunoResearch
Laboratories; West Grove, PA) and SuperSignal Chemiluminescent Substrate (ThermoFisher
Scientific; Waltham, MA; catalog# 34580), using a Mini-Med film processor. All
immunoblots were performed in triplicate.
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Serum and tissue adipokine arrays
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Adipokine protein expression levels in serum (n=3 per genotype) or eWAT (n=6–7 per
genotype) were assessed using mouse Proteome Profiler Adipokine Array kits (R&D
Systems; Minneapolis, MN; catalog# ARY013) according to manufacturer’s instructions.
Briefly, eWAT was homogenized in PBS with 10 μg/mL each aprotinin, leupeptin, and
pepstatin. After homogenization, Triton X-100 was added to each sample at 1% final
concentration. Samples were frozen at −80°C, thawed, and centrifuged at 10,000 × g for 5
minutes at 4°C to remove cellular debris. Sample protein concentrations were quantified
using a bicinchoninic acid assay with bovine serum albumin as the standard (Sigma-Aldrich,
St. Louis, MO). Serum assays were performed using 100ul of mouse serum as specified in
the kit instructions. Membranes were incubated with chemiluminescence reagents and then
exposed to autoradiography film for times ranging from one to five minutes. Film from the
five-minute exposure was used for densitometry analyses, which were performed with Image
Studio Lite software (Version 3.1; Li-Cor; Lincoln, NE). Densitometry values for each
adipokine were normalized to values for the reference spot on each membrane. Resulting
values were then compared between genotypes.
Isolation of eWAT SVCs for immunophenotyping
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Freshly excised eWAT was weighed, pooled (2–3 mice per pooled sample; 4 pooled samples
per genotype), and fractionated using previously described methods (10, 13), with minor
modifications (14) as briefly described here. Tissues were minced in ice-cold digestion
buffer (low glucose DMEM without phenol red; 5% heat-inactivated FBS; 1 mg/ml Type II
collagenase), transferred to 50 ml conical tubes, and placed into a shaking water bath at
37°C. Tissues were digested for 45 minutes at 100 rpm, with tubes being shaken vigorously
by hand every 10 minutes. In the last 5 minutes of the digestion procedure, EDTA was added
at a final concentration of 10mM. Each slurry was then passed through a pre-wet 100 μM
cell strainer into a 50-ml conical tube and the strainer rinsed with 10 ml PBS. Slurries were
centrifuged at 500xg for 10 minutes at 4°C. After centrifugation, floating adipocytes and
supernatant were removed and RBC lysis buffer was added to the remaining SVF pellet and
incubated for 5 minutes. Lysis buffer was neutralized with PBS, the SVF mixture passed
through a 40μm cell strainer into a 50 ml tube, the strainer rinsed twice with 5 ml PBS, and
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the tubes centrifuged at 500xg for 10 minutes at 4°C. The resulting SVF pellet was
resuspended in 3 ml of PBS and placed on ice for processing for flow cytometry analyses.
Viable cells were counted on a hemacytometer using trypan blue exclusion.
Flow cytometry analysis of SVCs
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SVCs (5 × 105 – 1 × 106 cells per tube) were isolated as described above and suspended in
flow cytometry staining buffer (eBioscience/Thermo Fisher; Waltham, MA; catalog
#00-4222) and incubated in Fc block for 10 minutes on ice. Cells were stained with
appropriate antibodies for 45 minutes at 4°C in the dark. All flow cytometry antibodies are
listed in Table 2. Stained SVCs were washed twice in PBS, fixed in 1% paraformaldehyde in
PBS, and analyzed on FACS Aria or FACS Calibur flow cytometers using Flow Jo software
(Version 10.0; TreeStar; Ashland, OR). Adipose tissue macrophages are identified as
CD45+, CD64+ (14, 15). Adipose tissue T cells are identified as CD45+, CD3+ (15).
Adipose tissue B cells are identified as CD45+, CD19+, and B220+. Preadipocytes were
identified as CD45-, CD31-, Sca1+ (16) and endothelial cells were identified as CD45-,
CD31+. Samples were analyzed on FACS Aria or FACS Calibur flow cytometers. Data were
analyzed using FlowJo software (Version 10.0; TreeStar; Ashland, OR). Gating strategies for
flow cytometry analyses are based on those previously described for adipose SVCs (3, 14,
15); auto fluorescence (no antibody) controls, single stain controls, and fluorescence minus
one isotype controls were used in each immunophenotyping panel for compensation settings
and to determine gating. Data were normalized per gram of eWAT or as a percentage of
SVCs, as indicated.
Statistical analyses
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GraphPad Prism software was used for all statistical analyses (Version 7.0; GraphPad
Software; La Jolla, CA), and results are expressed as mean ± SEM. Differences between
genotypes were analyzed using the Student’s t-test, with results considered significant when
p<0.05.

RESULTS
In this study, we examined the phenotypic effects of adipocyte-specific oncostatin M
receptor loss (OSMRFKO) in chow-fed male mice and littermate control OSMRfl/fl mice.
Specifically, we examined tissue weight, insulin responsiveness, adipokine production, and
stromal cell immunophenotypes in epididymal fat pads (eWAT), as well as serum adipokine
production.

Author Manuscript

Adipose and non-adipose expression of oncostatin receptor subunits
We observed significant decreases in OSMR gene and protein expression in two white fat
depots from OSMRFKO mice when compared to OSMRfl/fl mice (Figures 1A and 1B). The
levels of gp130 gene and protein expression did not differ significantly between the control
and knockout mice. There were no significant differences in either OSMR or gp130 gene
and protein expression between genotypes in brown adipose tissue (Figures 1A & 1B) or in
non-adipose tissues examined (Figures 1C & 1D). Notably, expression of OSM itself was
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significantly increased in the eWAT of OSMRFKO mice (Figure 1E); this increase in OSM
expression also occurs in obese high-fat fed OSMRFKO mice (10).
Adipose tissue response to an acute OSM challenge
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Acute OSM injection in OSMRfl/fl mice resulted in robust phosphorylation of STAT3 and
STAT5 tyrosine residues in eWAT. The reduced STAT phosphorylation in OSMRFKO mice
(Figures 2A and 2B) indicated a substantial decrease in responsiveness to an OSM
challenge. The observed effect on STAT5 phosphorylation was significant (p=0.0084; Figure
2B), while the effect on STAT3 followed the same trend but did not reach significance
(p=0.074; Figure 2B). These data also suggest that adipocyte OSMR is responsible for the
majority of OSM signaling in eWAT. Notably, basal levels of STAT3 and STAT5 tyrosine
phosphorylation in vehicle-injected mice were lower in the OSMRFKO group (Figures 2A
and 2B). OSM is known to induce ERKs 1&2 phosphorylation, but we did not observe a
significant reduction in ERK activation following acute OSM injection in OSMRFKO mice
compared to floxed littermate controls.
Body weight and blood glucose
Body weights did not significantly differ between OSMRfl/fl and OSMRFKO mice in any of
the experimental cohorts at the time of sacrifice (Figure 3A). Fasting blood glucose levels
also were not different between the two genotypes at the time of sacrifice (Figure 3B).
Insulin sensitivity and adipokine levels
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As a measure of insulin sensitivity, we examined insulin-stimulated Akt phosphorylation in
eWAT. Seven mice from each genotype were given intraperitoneal vehicle or insulin
injections and sacrificed 10 minutes later. Most of the insulin-injected OSMFKO mice had
reduced Akt phosphorylation compared to floxed controls. However, when the results from
all the mice were quantitated, the effects did not reach statistical significance (Figure 3C).
There were no differences in total Akt levels (Figure 3C and 3D). Further, we did observe
any significant changes in eWAT Glut1 or Glut4 gene expression levels [Glut1 relative
expression: 1.082 ± 0.125 AU (OSMRfl/fl) vs 1.028 ±0.061 AU (OSMRFKO); Glut4 relative
expression: 1.222 ± 0.237 AU (OSMRfl/fl) vs 1.238 ± 0.139 AU (OSMRFKO)] in eWAT.
Significant increases in CRP, ICAM-1, IGFBP6, and LCN2 were observed in OSMRFKO
eWAT (Figure 4A), while ICAM-1 and FETA were elevated in OSMRFKO serum (Figure
4B). The elevated ICAM-1 in both serum and eWAT in OSMRFKO mice suggests that the
eWAT may be the source of increasing circulating ICAM-1, although additional studies are
required to confirm this hypothesis.
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Adipokine expression in 3T3-L1 adipocytes
The lack of adipocyte OSMR signaling is associated with increased OSM expression in
eWAT of OSMRFKO mice, both in the current study (Figure 1E) and with high-fat diet
feeding (10). As shown in Figure 4A, OSMRFKO increased LCN2 levels in eWAT. To
determine if OSM could induce Lcn2 gene expression in a cell-autonomous manner, we
studied the effects of OSM in cultured adipocytes. We observed that a 6-hour treatment with
OSM strongly induced Lcn2 expression in 3T3-L1 adipocytes. Use of the MEK inhibitor,
Obesity (Silver Spring). Author manuscript; available in PMC 2019 September 01.
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U0126, demonstrated that this effect was primarily ERK-dependent (Figure 5A). The
efficacy of ERK inhibition was confirmed by western blotting that demonstrated a
significant reduction in ERK phosphorylation following inhibitor treatment (data not
shown). OSM, however, did not induce Igfbp6 expression in adipocytes (Figure 5B).
Interestingly, OSM induced Icam1 expression and ERK inhibition further increased this
effect (Figure 5C). Previous studies have reported Crp and FetA expression and secretion by
adipocytes (17, 18); however, we were not able to detect either gene in our experiments in
3T3-L1 adipocytes.
Immunophenotyping of SVC populations

Author Manuscript

Though eWAT weights did not differ (Figure 6A), OSMRfl/fl mice had a significantly higher
number of SVCs per gram of eWAT than OSMRFKO mice (Figure 6B). However,
immunophenotyping analyses indicated significantly higher CD45+ leukocytes in
OSMRFKO eWAT when compared to OSMRfl/fl eWAT (Figure 6B). While not significant,
there were trends towards increased CD19+/B220+ B cells (p=0.07) and increased CD3+ T
cells in OSMRFKO eWAT when compared to OSMRfl/fl control mice (Figures 6C and 6D,
respectively). No obvious trends were observed in CD64+ adipose tissue macrophages or in
endothelial cells between groups (Figures 6E and 6F). Although not statistically significant,
a modest increase in Sca1+ preadipocytes was observed in the OSMRFKO mice (Figure 6G).

DISCUSSION
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Our previous work indicates that OSMRFKO mice exhibit systemic insulin resistance and
adipose tissue inflammation when challenged with a high-fat diet (10). Here, we studied the
phenotype of OSMRFKO mice in the absence of a high-fat diet challenge and more closely
examined the adipose tissue inflammatory profile in the OSMRFKO mouse. There are several
significant observations from this study. Notably, adipocyte-specific OSMR deletion does
not alter body mass or fasting blood glucose, but does modestly blunt adipose tissue insulin
sensitivity in chow-fed mice. In addition, adipose tissue and serum pro-inflammatory
adipokine expression levels are increased in chow-fed OSMRFKO mice. These results are
consistent with the significant increase in the number of adipose tissue leukocytes (Figure
6B) and the trend towards increased T cell and B cell numbers, despite no changes in
adipose tissue weight. The observed phenotypic effects in chow-fed OSMRFKO mice are not
due to alterations in gp130 expression in adipose tissue or in gp130 and/or OSMR
expression in non-adipose tissues. Taken together, these results and our previous data (10)
demonstrate that the adipose tissue dysfunction in OSMRFKO mouse is characteristic of the
genotype itself and occurs in the absence of obesity.
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Our current results in OSMRFKO mice contrast with those of the global OSMR knockout
mice fed a chow diet (19). Global OSMR knockout mice of similar age to the OSMRFKO
mice in our study have increases in body mass, eWAT and iWAT mass, liver mass, and food
intake when compared to OSMRfl/fl mice (19). We did not observe changes in any of these
parameters in chow-fed OSMRFKO mice. Further, global OSMR knockout mice also exhibit
significant increases in blood glucose and serum insulin and are generally glucose intolerant
and insulin resistant (19), while our OSMRFKO mice are not. However, much like the
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OSMRFKO mice, global OSMR knockout mice exhibit increased adipose tissue
inflammation. The vast differences in these phenotypes underscore the importance of OSMR
in hematopoiesis, liver development, and other developmental functions, and suggest that
many of the metabolic effects observed in the global OSMR knockout mice are due to nonadipocyte effects (19, 20, 21). Some of the molecular mechanisms by which specific
disruption of adipocyte OSM-OSMR signaling axis promotes adipose tissue dysfunction still
remain unclear, although our current data provide new information.
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As a first step toward examining drivers of the adipose tissue dysfunction in chow-fed
OSMRFKO mice, we generated adipokine profiles using antibody arrays. We analyzed 38
adipokines, and found four of them were differentially expressed at significant levels: Creactive protein (CRP), intercellular adhesion molecule 1 (ICAM-1), insulin-like growth
factor binding protein 6 (IGFBP6), and lipocalin 2 (LCN2). Various cell types produce these
proteins, all of which have established effects in inflammation. Immune cells can produce all
four of these proteins; however, adipocytes are reported to produce at least two of them
(CRP and LCN2). CRP is an acute phase protein synthesized primarily by the liver in
response to cytokines or other inflammatory stimuli. Previous reports suggest that
adipocytes can produce CRP in response to inflammatory stimuli (17, 18), although we were
unable to detect Crp gene expression in our in vitro 3T3-L1 adipocyte experiments.
Adipocytes produce LCN2 in response to pro-inflammatory cytokine exposure (22, 23, 24)
and several immune cell types also produce LCN2 (25). However, substantial evidence
indicates that circulating LCN2 is liver–derived and produced in response to infection or
injury (26, 27), so it is not surprising that the changes we observed in LCN2 levels in this
study were only at the level of the eWAT itself and not in serum (Figure 4B). The role of
LCN2 in adipose tissue is generally thought to be pro-inflammatory, since increasing its
expression promotes neutrophil recruitment and induces pro-inflammatory cytokine
production (28, 29), although anti-inflammatory effects have been reported in other tissues
(30, 31). Our in vitro studies clearly indicate that OSM potently induces adipocyte LCN2
expression and that this induction is ERK-dependent (Figure 5A). TNFα and IFNγ are also
potent inducers of LCN2 in cultured murine adipocytes (23).
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ICAM-1 is a cell surface glycoprotein found on endothelial cells and leukocytes that is
induced by pro-inflammatory cytokine production and interacts with β-integrins to facilitate
leukocyte migration (32). Several studies report that adipocytes can express ICAM-1 (33,
34, 35). Our in vitro experiments indicated that, while Icam1 gene expression was very low
in basal conditions, but OSM treatment substantially induced Icam1 mRNA levels in
adipocytes (Figure 5). The significant elevations of ICAM-1 in both serum and eWAT in
OSMRFKO mice when compared to floxed controls (Figure 4) is consistent with the elevated
OSM levels we observe in in OSMRFKO mice. Our flow cytometry data also demonstrated
increased leukocyte numbers in OSMRFKO adipose tissue. Given its known functions in
leukocyte migration and recruitment, we hypothesize that ICAM-1 is either induced in
adipocytes by immune cell-derived factors, produced by immune cells alone, or both, and
may act to effectively trap leukocytes in the eWAT of the OSMRFKO mouse. Further studies
are required to evaluate this hypothesis.
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Increased levels of fetuin A (FETA), a negative acute phase protein primarily secreted from
liver (36), are associated with metabolic syndrome and insulin resistance in humans and
animals (37, 38, 39). In adipose tissue, FETA serves as an endogenous toll-like receptor 4
(TLR4) ligand, where it binds fatty acids for presentation to TLR4 and subsequently triggers
pro-inflammatory cytokine production via the NF-kB pathway (38). FETA can also promote
macrophage migration into adipose tissue (37) and directly interfere with insulin receptor
action to mediate insulin resistance (39). Data from these previous studies coincide with
results obtained in OSMRFKO mice where we observed significant increases in serum FETA
(Figure 4B) and a modest blunting of eWAT insulin signaling in comparison to OSMRfl/fl
mice.
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A family of six IGFBPs controls the activity of insulin-like growth factors; the IGFBPs all
serve to inhibit IGF actions. Of these IGFBPs, IGFBP6 has garnered interest for its high
specificity for IGF-II and for its IGF-independent roles, such as the promotion of apoptosis
and inhibition of angiogenesis (40, 41). Literature addressing the possible role of IGFBP6 in
adipose tissue is scant; however, recent evidence suggests that in some inflammatory
conditions IGFBP6 may be a possible chemotactic factor (40). In this study, we observed
significant increases in IGFBP6 levels in OSMRFKO eWAT when compared to OSMRfl/fl
eWAT. It is possible that, if IGFBP6 acts with chemotactic ability in adipose tissue, the
increased IGFBP6 in OSMRFKO eWAT could be partially responsible for the significantly
higher number of leukocytes measured in the tissue.
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Collectively, our prominent adipokine array results suggest a local pro-inflammatory
environment in the adipose tissue of the OSMRFKO mouse that occurs in the absence of
obesity. In further support of these observations, flow cytometry analyses revealed elevations
of leukocytes, B cells, and T cells in OSMRFKO eWAT (Figure 6). While it remains unclear
as to which cells in the adipose tissue are responsible for the increased adipokine production,
it is clear that the loss of adipocyte OSM-OSMR signaling disrupts adipose tissue
homeostasis in the absence of obesity. Likely, more than one cell type is contributing to this
effect, as there is known crosstalk among cell types in adipose tissue. Future studies will
more closely examine each cell type in the adipose tissue of the OSMRFKO mouse to better
determine their roles in contributing to disrupted adipose tissue homeostasis. Despite the
evident adipose tissue dysfunction in chow-fed OSMRFKO mice, a systemic metabolic
challenge, such as an obesogenic diet, is required to produce whole-body insulin resistance
while perpetuating adipose tissue inflammation in these animals (10). Taken together, these
results and our previous results strongly suggest the need for intact adipocyte OSM-OSMR
signaling in maintaining adipose tissue homeostasis.
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What is already known about this subject?
•

Adipose tissue oncostatin M (OSM) protein and gene expression are
significantly induced in obese rodents and in people with obesity.

•

Obese mice with adipocyte-specific deletion of the oncostatin M receptor
(OSMR) exhibit systemic insulin resistance and increased adipose tissue
immune cell infiltration.

What does our study add?

Author Manuscript

•

Altered pro-inflammatory adipokine production observed in the adipocytespecific OSMR knockout mouse occurs in the absence of high-fat dietinduced obesity.

•

Adipose tissue immune cell infiltration and adipose tissue dysfunction are
present in non-obese adipocyte-specific OSMR knockout mice.
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Figure 1. Expression levels of OSMR and gp130 are not altered in non-adipose tissues
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Tissue expression of OSMR and gp130 in various adipose depots at the A) gene and B)
protein levels in OSMRfl/fl (CTL) and OSMRFKO (KO) chow-fed mice. Non-adipose tissue
expression of OSMR and gp130 at the C) gene and D) protein levels was also measured. E)
Gene expression of OSM itself was also measured in various adipose depots. Total RNA in
various tissues was purified and analyzed by real-time PCR. Cyclophilin A (Ppia) was used
as an endogenous control. Protein (100 ug for adipose tissues, 50 ug for all other tissues)
was subjected to Western blot analysis. Data are shown as mean ± SEM. For PCR, n=8 per
genotype (eWAT), n=3–4 per genotype (inguinal WAT (iWAT), brown adipose tissue (BAT),
other tissues). ***p < 0.001, *p<0.05 vs. OSMRfl/fl. AU, arbitrary units.
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Figure 2. OSMRFKO mice are less responsive to an acute OSM challenge
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A) Effects of acute OSM or vehicle injection (15 min) on STAT and ERK phosphorylation in
eWAT of chow-fed OSMRfl/fl (n=4) or OSMRFKO mice (n=4). 75 ug protein was subjected
to Western blot analysis. B) Densitometry analyses were conducted using Image Studio
software. Data are shown as mean ± SEM and are representative of two independent
experiments. AU, arbitrary units.
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Figure 3. OSMRFKO mice exhibit a modest blunting of insulin-induced Akt phosphorylation

A) Body weights, B) 4-hour fasting blood glucose, and C) protein expression levels of Akt,
phosphoAkt, and phosphoERK in eWAT from chow-fed OSMRfl/fl and OSMRFKO (KO)
mice. Body weights and blood glucose levels were not significantly different between
genotypes. 100 ug protein was subjected to Western blot analysis. KO mice exhibited a
slight diminution in Akt phosphorylation (S473) in eWAT. Densitometry analysis of D)
pAkt/Akt ratio was conducted using Image Studio software. For vehicle injections, n=3 per
genotype and for insulin injections, n=4 per genotype. Data are shown as mean ± SEM. AU,
arbitrary units.
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Figure 4. Increased pro-inflammatory adipokine expression in eWAT and serum of OSMRFKO
mice

Protein expression levels of various adipokines in A) eWAT (n=6–7 per genotype) and B)
serum (n=3 per genotype) of chow-fed OSMRfl/fl (grey bars) and OSMRFKO (black bars)
mice. CRP, ICAM-1, IGFBP6, and LCN2 expression levels were significantly increased in
eWAT of the OSMRFKO mice when compared to OSMRfl/fl mice, and we observed
significant increases in FETA and ICAM-1 in the serum of OSMRFKO mice when compared
to OSMRfl/fl mice. Data are presented as mean ± SEM. *p<0.05 vs. OSMRfl/fl.
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Figure 5. Adipokine gene expression in 3T3-L1 adipocytes in response to OSM treatment and/or
ERK inhibition
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Fully differentiated 3T3-L1 adipocytes were treated with 1 nM or OSM or vehicle for 6
hours in the presence/absence of the ERK inhibitor U0126. Gene expression levels of A)
Lcn2, B) Igfbp6, C) Icam1, Crp, and FetA were assessed, but Crp and FetA were not
detected. Total RNA was purified from cells and analyzed by real-time PCR. Ubiquitin b
(Ubb) was used as an endogenous control.

Author Manuscript
Author Manuscript
Obesity (Silver Spring). Author manuscript; available in PMC 2019 September 01.

Stephens et al.

Page 19

Author Manuscript
Author Manuscript

Figure 6. Leukocyte accumulation and altered immune cell populations in eWAT of OSMRFKO
mice

A) Epididymal fat pad (eWAT) weight, B) number of SVF cells per gram eWAT and CD45+
leukocytes as determined by flow cytometry in chow-fed OSMRfl/fl (CTL; grey bars) and
OSMRFKO (KO; black bars) mice (n=4 groups of pooled tissue per genotype; 2–3 mice per
pool). Quantification of eWAT stromal vascular cells was performed using flow cytometry
and data are presented as % SVCs for C) B cells (CD19+/B220+), D) T cells (CD3+), E)
macrophages (CD64+), F) endothelial cells (CD31+), and G) preadipocytes (CD31-/Sca1+).
Data presented are mean ± SEM. *p<0.05 and ** p<0.01 vs. OSMRfl/fl.
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Sequences for qPCR primers used in this study.
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Gene

Forward Sequence

Reverse Sequence

Crp

CAG CAG CAT CCA TAG CCA T

TGC TTC CAG AGA CAC ATA GGA

FetA (Ahsg)

CTT CAG GGA TTC AAA CAG GTC T

CAA AGC ATG GCA AGT GGT C

Glut1 (Slc2a1)

AGT TCG GCT ATA ACA CTG GTG

GTG GTG AGT GTG GTG GAT G

Glut4 (Slc2a4)

TCT TAT TGC AGC GCC TGA G

GAG AAT ACA GCT AGG ACC AGT G

gp130

AGG AGA AAT AGA AGC CAT AGT CG

TGG AAG GAT CAG GAA CAT TAG G

Icam1

CTG TGC TTT GAG AAC TGT GG

GGT CCT TGC CTA CTT GCT G

Igfbp6

TCT ATG TGC CAA ACT GTG ACC

CTG AGT GCT TCC TTG ACC ATC

Lcn2

TGC AAG TGG CCA CCA CGG AC

GCA TTG GTC GGT GGG GAC AGA GA

Osmr

CGT TCC CCT GTG AGG CCG AG

TCC TCC AAG ACT TCG CTT CGG G

Ppia

CCA CTG TCG CTT TTC GCC GC

TGC AAA CAG CTC GAA GGA GAC GC

Ubb

CCA GTG GGC AGT GAT GG

GCT TAC CAT GCA ACA AAA CCT
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Flow cytometry antibodies used in this study.
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Antibody

Clone

Vendor

CD45.2

104

eBioscience/ThermoFisher

CD64

X54-5/7.1

BD Biosciences

CD31

390

eBioscience/ThermoFisher

CD19

1D3

eBioscience/ThermoFisher

B220

RA3-6B2

eBioscience/ThermoFisher

CD3

145-2C11

eBioscience/ThermoFisher

Sca1

D7

eBioscience/ThermoFisher

CD16/CCD32 (Fc block)

93

eBioscience/ThermoFisher

Mouse IgG2aκ

eBM2a

eBioscience/ThermoFisher

Mouse IgG1κ

P3.6.2.8.1

eBioscience/ThermoFisher

Rat IgG2aκ

eBR2a

eBioscience/ThermoFisher

Armenian hamster IgG

eBio299Arm

eBioscience/ThermoFisher
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